SCHEMBL890317

SCHEMBL890317

OCCc1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515167 0.89 — —
SCHEMBL8963903 0.87 HRH3 (0.73) —
SCHEMBL4687435 0.87 HRH3 (0.66) —
SCHEMBL8964986 0.82 HRH3 (0.79) —
SCHEMBL8963886 0.82 HRH3 (0.75) —
SCHEMBL1268284 0.82 — —
SCHEMBL27699577 0.80 — —
Hydrochloric Acid SCHEMBL7090498 0.80 — —
SCHEMBL8963957 0.80 HRH3 (0.80) —
SCHEMBL2006357 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119711031-B Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-06-24 — — CN claimed
CN-119711031-A Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-03-28 — — CN claimed
CN-1298305-A Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2001-06-06 — — CN claimed
US-20260138990-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS INC (US) 2026-05-21 — — US disclosed
EP-4702026-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2026-03-04 — — EP disclosed
CN-119711031-B Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-06-24 — — CN disclosed
CN-119711031-A Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-03-28 — — CN disclosed
WO-2024226685-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS, INC. (US) 2024-10-31 — — WO disclosed
US-20230330254-A1 ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2023-10-19 — — US disclosed
US-20230330254-A1 ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2023-10-19 — — US disclosed
CN-116843050-A Method, system, equipment and medium for predicting railway freight traffic 中国铁道科学研究院集团有限公司运输及经济研究所 2023-10-03 — — CN disclosed
US-20120009260-A1 NANOPARTICLE FILM DELIVERY SYSTEMS AQUESTIVE THERAPEUTICS, INC. 2012-01-12 — — US disclosed
US-7960394-B2 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-14 — — US disclosed
US-20100168156-A1 Novel Benzoxathiine Derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-07-01 — — US disclosed
US-20080275069-A1 Quinazoline Derivative MSD K.K. (JP) 2008-11-06 — — US disclosed
EP-1944301-A1 NOVEL BENZOXATHIIN DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-07-16 — — EP disclosed
EP-1757594-A1 QUINAZOLINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-02-28 — — EP disclosed
CN-1217666-C Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2005-09-07 — — CN disclosed
CN-1298305-A Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2001-06-06 — — CN disclosed
EP-0437103-A2 Substituted 5-(alkyl)carboxamide imidazoles SMITHKLINE BEECHAM CORPORATION (US) 1991-07-17 — — EP disclosed
Send feedback